Please assess the completion status of the following clinical trial:

Trial Title: Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~  * Patients with advanced or metastatic renal cell carcinoma, histologically confirmed, with at least one radiological response assessment~ * Patients who had received Axitinib treatment in second or further line with a PFS ≥9 months or DP (disease progression) at the first tumor assessment.~ * For the patients alive at the moment of the inclusion, patients must have a signed informed consent document~Exclusion Criteria:~* Axitinib received out of the approved indication Patients who do not meet any of the inclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).